Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period
NCT07400614 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2026-04-13
Summary
The primary purpose of the research is to evaluate in healthy adults the time course effects of energy drink formulas containing 120 mg caffeine with varying levels of taurine and b vitamins on subjective alertness in the presence of cognitive load assessed hourly up to 5 hours post dose
Conditions
- Alertness
Interventions
- OTHER
-
All beverages are flavor and color matched
Caffeine with varying amounts of taurine and B vitamins
- OTHER
-
Flavored carbonated beverage, color-matched
Base with 0 mg caffeine, taurine, vitamins
Sponsors & Collaborators
-
PepsiCo Global R&D
lead INDUSTRY
Principal Investigators
-
Crystal Haskell-Ramsay, PhD · Northumbria U Newcastle, UK
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-26
- Primary Completion
- 2026-08-30
- Completion
- 2026-08-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Effects of Energy Drinks on Sleep and Cardiovascular Health
NCT05503732 ·Status: COMPLETED ·Phase: NA
-
Effect of Energy Drink on Sport Performance and Psycho-Physiological Responses.
NCT03936712 ·Status: COMPLETED ·Phase: NA
-
Nutrient-Fortified Beverage Study
NCT02103192 ·Status: COMPLETED ·Phase: NA
-
Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers
NCT04281758 ·Status: COMPLETED ·Phase: PHASE1
-
Energy Drinks and Vascular Function
NCT03324256 ·Status: COMPLETED ·Phase: NA
-
Effects of Energy Drinks
NCT02727920 ·Status: COMPLETED ·Phase: NA
-
A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators
NCT05998096 ·Status: COMPLETED ·Phase: NA
-
Effects of Variations in Caffeinated Beverages on Well-being
NCT07404254 ·Status: RECRUITING ·Phase: NA
-
Impact of Energy Drink Brands on Heart Rhythm
NCT03196908 ·Status: COMPLETED ·Phase: NA
-
Plant Based Extracts and Cognition
NCT02202629 ·Status: UNKNOWN ·Phase: NA
-
Impact of Energy Drinks and Panax Ginseng on Heart Rhythm
NCT02572102 ·Status: UNKNOWN ·Phase: NA
-
Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes
NCT05559372 ·Status: COMPLETED ·Phase: NA
-
Effects of Chronic Energy Drink Consumption on Cardiometabolic Endpoints
NCT03840863 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects of Energy Drinks in Healthy Adults
NCT01940822 ·Status: COMPLETED ·Phase: NA
-
Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage and Associated Mood and Physiological Effects
NCT05096780 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers
NCT03021616 ·Status: TERMINATED ·Phase: NA
-
Investigation of the Acute Calming Effects of Drinks Containing Herbal Extracts in Healthy Adults
NCT02675582 ·Status: COMPLETED ·Phase: NA
-
Post-Exercise Cardiovascular Responses Following Energy Drink Consumption
NCT03418077 ·Status: COMPLETED ·Phase: NA
-
The Influence of Energy Drinks on the Blood Oxygenation Concentration of the Optic Nerve
NCT01827150 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Impact of Energy Drinks on Cardiovascular Endpoints
NCT01329679 ·Status: TERMINATED ·Phase: NA
-
The Acute Effects of Caffeine on Exercise and Cognition
NCT03400423 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Caffeine on Heart Function
NCT02401776 ·Status: COMPLETED ·Phase: NA
-
"How Awareness and Subjectivity Modulate the Placebo Effect"
NCT06533137 ·Status: RECRUITING ·Phase: NA
-
Effects of Caffeinated Beverages on Well-being
NCT07357818 ·Status: RECRUITING ·Phase: NA
-
The Effect of Energy Drink on Cardiovascular Variables: A Randomized Controlled Trial
NCT03841838 ·Status: COMPLETED ·Phase: NA